Someone tells me their bloodwork came back completely normal, and they still can’t get off the couch. I hear some version of that constantly with ME/CFS. You get a virus, you never bounce back, and then someone tells you to sleep more or maybe try yoga. Like you haven’t already tried everything.
The problem is that ME/CFS doesn’t behave like ordinary tiredness. It affects multiple systems in the body at once, and it can take over your whole life while standard lab tests may not always explain what is happening.
We don’t have a cure. That’s just true. But the science around what’s actually happening in the body has come a long way, and researchers and clinicians are increasingly moving toward personalized approaches that look at individual symptoms, biological differences, and potential drivers of illness rather than applying the same treatment plan to everyone.
“ME/CFS affects every patient differently,” says Dr. Inbar Almon Tofan, Medical Doctor and Medical Supervisor at the Apheresis Center. “Our goal is not to fit patients into a standard protocol but to understand the factors driving their symptoms and build a treatment strategy around those findings.”
Why One Treatment Doesn’t Work for Everyone
You’re not just tired. You’re dealing with fatigue that doesn’t quit, post-exertional malaise, brain fog thick enough to make a grocery list feel like a math test, sleep that never actually restores you, joint and muscle pain, dizziness, and an autonomic system that turns standing up too fast into a real problem.
Nobody has identified one single cause of ME/CFS. Instead, research suggests that different biological pathways may be involved in different people. Some patients show signs of immune system changes. Others may experience autonomic nervous system dysfunction, inflammation, changes in circulation, or differences in how their cells produce energy.
This variation is exactly why personalized care has become such an important part of understanding the condition. Instead of assuming every person has the same underlying problem, clinicians are increasingly looking at individual patterns, symptoms, and measurable health markers to guide decisions.
The goal is not necessarily to “fix” the illness with one solution, but to improve function, manage symptoms, and create a strategy that reflects what is happening in each person’s body.
Why Individualized Care Matters
Many people with ME/CFS spend years searching for answers. They may try multiple approaches without meaningful improvement, not because those options were necessarily ineffective, but because the treatment may not have addressed the specific factors influencing their symptoms.
A personalized evaluation can involve a detailed medical history, symptom tracking, laboratory testing, nutritional assessment, sleep evaluation, and assessments of areas such as cardiovascular or autonomic function when appropriate. Looking at these different pieces together can help clinicians understand patterns that may not be visible from a single test.
“Listening carefully to patients remains one of the most valuable diagnostic tools we have,” Dr. Almon Tofan explains. “Patterns often emerge that cannot be appreciated through laboratory testing alone.”
This highlights an important part of personalized medicine: biological data matters, but so does understanding the individual experience of the disease.
Because symptoms can change significantly over time, an effective care plan also needs flexibility. Regular reassessment allows recommendations to evolve as a person’s condition changes.
Managing Daily Life with ME/CFS
Here’s a real problem with this illness: you push yourself a little too hard on Tuesday, and the crash doesn’t hit until Thursday. That delay is what makes post-exertional malaise so difficult to manage. You do something that felt fine at the time, and days later your body responds.
Pacing is one of the most commonly discussed strategies for managing ME/CFS. It involves understanding personal limits, recognizing patterns, and balancing activity with available energy instead of repeatedly pushing beyond what the body can handle.
Beyond pacing, many people benefit from addressing additional factors that may contribute to symptom severity, including sleep difficulties, nutritional concerns, chronic pain, or issues related to circulation and autonomic function.
Personalized care focuses on identifying which areas are most relevant for each person rather than assuming every patient needs the same combination of interventions.
Where Supplements Fit In
People often ask about supplements when discussing ME/CFS, and it makes sense why. Since cellular energy production and metabolism are areas of ongoing research, nutrients involved in these processes have received attention.
CoQ10 and D-ribose are often discussed because of their roles in cellular energy pathways. Magnesium, B vitamins, and other nutrients may also be considered when deficiencies are identified.
However, supplements are most useful when they are part of a broader understanding of an individual’s health status. Taking multiple products without knowing whether they address a specific need may not provide meaningful benefits and can sometimes create unnecessary risks.
Personalized approaches consider laboratory findings, existing medications, and individual health factors before recommending additional support.
Emerging Treatment Approaches
Long COVID changed the conversation around ME/CFS. Researchers noticed significant overlap between the two conditions, leading to increased attention on areas such as immune function, inflammation, vascular health, and energy metabolism.
As research continues, many experts are exploring how biomarkers and individualized assessments could improve the way ME/CFS is diagnosed and managed. The future of care may depend less on finding one universal treatment and more on understanding which biological pathways are most relevant for each patient.
Clinics built around this illness are increasingly combining standard medical care with treatment plans tailored to the individual. The chronic fatigue syndrome treatment offered at Apheresis Center is a good example. Patients go through a full evaluation first, and the recommendations come out of that, not a template pulled off a shelf.
Results can vary significantly from person to person. Some individuals may respond to certain approaches while others require different adjustments. This variability reinforces why personalized medicine is becoming increasingly important in chronic conditions like ME/CFS.
Looking Ahead
Ten years ago, many people with ME/CFS struggled to have the complexity of their condition recognized. Today, it is increasingly understood as a multisystem illness involving different biological processes that can vary widely between individuals.
That progress is already influencing patient care. Researchers are identifying new areas for investigation, diagnostic approaches are becoming more individualized, and specialists from different fields are working together to better understand the condition.
“Progress in ME/CFS research is happening because clinicians, researchers, and patients are working together,” says Dr. Almon Tofan. “Every new insight helps us move closer to more effective and more personalized treatment strategies.”
Living with ME/CFS remains challenging, and no single approach works for everyone. What is changing is the way the condition is understood. By combining patient experiences with scientific research, diagnostics, and a better understanding of individual biology, personalized care offers a more targeted path toward improving quality of life and supporting long-term health.
